Stock Price Quote

CONCORD DRUGS LTD.

NSE : NABSE : 538965ISIN CODE : INE858L01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE37.59-1.18 (-3.04 %)
PREV CLOSE ( ) 38.77
OPEN PRICE ( ) 38.77
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4532
TODAY'S LOW / HIGH ( )37.11 40.00
52 WK LOW / HIGH ( ) 25.5661.5
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1995
Management Info
S Nagi Reddy - Chairman S Nagi Reddy - Managing Director
Registered Office

Address Survey No.249,Brahmanapally Village,Hayatnagar Mandal,
Rangareddy Dist,
Telangana-501511

Phone 09052779505

Email concorddrugsltd@gmail.com

Website www.concorddrugs.in

Registrars Details
Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE, Ahmedabad

NEWS

19Mar Board Meeting Outcome for Appointment
Appointment of Ms. Namratha Nagla (ACS-68979) as Company Secretary Cum C..
20Jan Concord Drugs informs about certificate
Concord Drugs has informed that it enclosed Certificate under Regulation..
16Oct Concord Drugs informs about disclosures
Concord Drugs has informed that it enclosed the disclosure under Regulat..
12Sep Concord Drugs informs about newspaper
Concord Drugs has informed that it enclosed clippings of the Newspaper A..
17Aug Concord Drugs informs about newspaper
Concord Drugs has informed that it enclosed newspaper clippings as per R..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-2.390000000000018.90999999999998
Gross Profit -2.55000000000001 11.24
Operating Profit 5.6199999999999943.52
Net Sales 126.24513.23

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  6660.85 (7.79%)
M.Cap ( in Cr)8545.80
Concord Biotech (BSE)
peergroup  1561.65 (3.68%)
M.Cap ( in Cr)16337.39
Sanofi India (BSE)
peergroup  8490.90 (0.51%)
M.Cap ( in Cr)19555.07
JB Chem & Pharma (BSE)
peergroup  1800.50 (2.37%)
M.Cap ( in Cr)27942.82
Divi's Lab (BSE)
peergroup  3779.20 (1.08%)
M.Cap ( in Cr)100325.89

Shareholding Pattern

PROMOTERS 55.41%
NON-INSTITUTION 44.59%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Concord Drugs Ltd.

Concord Drugs Ltd. was incorporated in the year 1995. Its today's share price is 37.59. Its current market capitalisation stands at Rs 37.59 Cr. In the latest quarter, company has reported Gross Sales of Rs. 513.14 Cr and Total Income of Rs.513.23 Cr. The company's management includes Namratha Nagla, Sumeela Kasu, K Ramachandra Reddy, S Nagavenkata Hareesh, S Manoj Kumar Reddy, S Koni Reddy, S Nagi Reddy, S Nagi Reddy.

It is listed on the BSE with a BSE Code of 538965 , NSE with an NSE Symbol of and ISIN of INE858L01010. It's Registered office is at Survey No.249,Brahmanapally Village,Hayatnagar MandalRangareddy Dist-501511, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are MM Reddy & Co, NG Rao & Associates, Pundarikashyam & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.